Report overview
Over the recent years, the global Hepatitis B Treatment industry has been driven by the increasing number of patients diagnosed with Chronic Hepatitis B which results in severe complications, rising awareness about the consequences of viral infection, rigorous efforts to eliminate the viral infection, improving surveillance and diagnostic facilities, significant number of drugs in pipeline with better efficacy coupled with emerging vaccines with lower dosage and better effectiveness. Globally, the growth in Hepatitis B Treatment market is driven by backed by growing middle class population group demanding better drugs to improve lifestyle.
This report contains market size and forecasts of Hepatitis B Virus (HBV) in Global, including the following market information:
Global Hepatitis B Virus (HBV) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Hepatitis B Virus (HBV) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Therapeutics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hepatitis B Virus (HBV) include Merck, Gilead Sciences, Novartis, GlaxoSmithKline, Hoffmann, La Roche and Bristol-Myers Squibb, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hepatitis B Virus (HBV) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis B Virus (HBV) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hepatitis B Virus (HBV) Market Segment Percentages, by Type, 2021 (%)
Therapeutics
Vaccine
Global Hepatitis B Virus (HBV) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hepatitis B Virus (HBV) Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Global Hepatitis B Virus (HBV) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hepatitis B Virus (HBV) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatitis B Virus (HBV) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Hepatitis B Virus (HBV) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Gilead Sciences
Novartis
GlaxoSmithKline
Hoffmann
La Roche
Bristol-Myers Squibb
